Home › Funds › PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. › RPRX
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. position in RPRX
ROYALTY PHARMA PLC · Health Care
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. reported holding 510,625 shares of RPRX (ROYALTY PHARMA PLC) in its Q3 2026 13F filing — a position valued at US$29.8M, representing 1.51% of its reported portfolio and ranking #17 among its reported holdings. PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. has disclosed RPRX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.'s RPRX position evolved
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. first disclosed a stake in RPRX in Q1 2024 at 368,916 shares (US$11.2M). The position peaked in Q2 2026 at 597,938 shares, worth US$33.5M. Across 11 filings, PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. increased the stake 6 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 510,625 shares valued at US$29.8M — a reduction of -87,313 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 368.92K | $11.20M | New |
| Q2 2024 | 424.54K | $11.20M | Add |
| Q3 2024 | 461.05K | $13.04M | Add |
| Q4 2024 | 472.21K | $12.05M | Add |
| Q1 2025 | 573.60K | $17.86M | Add |
| Q2 2025 | 595.96K | $21.47M | Add |
| Q3 2025 | 595.89K | $21.02M | Hold |
| Q4 2025 | 600.17K | $23.19M | Add |
| Q1 2026 | 598.62K | $28.72M | Hold |
| Q2 2026 | 597.94K | $33.53M | Hold |
| Q3 2026 | 510.62K | $29.80M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RPRX and 13F data
RPRX (ROYALTY PHARMA PLC) is a Health Care company. 47 other funds we track also report a position in RPRX — the largest reported positions include Swedbank AB (US$598.8M), Baillie Gifford & Co (US$534.1M), ROYAL LONDON ASSET MANAGEMENT LTD (US$348.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RPRX
- Swedbank AB 10.26M sh · $598.81M · Q3 2026
- Baillie Gifford & Co 9.15M sh · $534.11M · Q3 2026
- ROYAL LONDON ASSET MANAGEMENT LTD 5.97M sh · $348.63M · Q3 2026
- Caledonia (Private) Investments Pty Ltd 5.78M sh · $323.85M · Q2 2026
- EFG International AG 3.94M sh · $229.51M · Q3 2026
- Patient Capital Management, LLC 3.42M sh · $199.71M · Q3 2026
- Dorsey Asset Management, LLC 2.42M sh · $140.98M · Q3 2026
- Regal Partners Ltd 2.45M sh · $137.25M · Q2 2026
- HOMESTEAD ADVISERS CORP 1.66M sh · $96.68M · Q3 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.52M sh · $88.60M · Q3 2026
More on PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.
FAQ
How long has PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. held RPRX?
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. has disclosed RPRX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.'s current position in RPRX?
As of Q3 2026, PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. holds 510.62K shares of RPRX (ROYALTY PHARMA PLC), valued at $29.80M, representing 1.51% of its reported portfolio and ranking #17.
Has PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. been buying or selling RPRX?
In the latest 13F filing (Q3 2026), PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. reduced its position in RPRX. The position peaked in Q2 2026 at 597.94K shares.
Which other funds hold RPRX?
Other major institutional holders of RPRX include Swedbank AB, Baillie Gifford & Co, ROYAL LONDON ASSET MANAGEMENT LTD, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.